< Back to insights hub


WFW advises Principia on investment in CrestOptics27 June 2018

Share this Page
Share this Page

Watson Farley & Williams (“WFW”) advised Principia SGR S.p.A. on its investment in CrestOptics S.p.A. through a €5m+ share capital increase subscription.

The investment was made through its Principia III-Health Fund, which will hold a qualified shareholding in CrestOptics’ capital.

Principia SGR is a leading asset management company, specialising in closed-end funds for venture and growth capital, and investing in innovative small and medium-sized enterprises (SMEs), high tech and start-ups based on new scientific research.

CrestOptics S.p.A. is an Italian headquartered developer and manufacturer of confocal and super-resolution scanners for optical microscopes.

The WFW Italy Corporate team advising Principia was led by Partner Carlo Cosmelli. He was assisted by Associates Alexandra Clinciu and Magdalena Bagli.

Share this Page

Keep in touch